DE2501649C3 - Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel - Google Patents

Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE2501649C3
DE2501649C3 DE2501649A DE2501649A DE2501649C3 DE 2501649 C3 DE2501649 C3 DE 2501649C3 DE 2501649 A DE2501649 A DE 2501649A DE 2501649 A DE2501649 A DE 2501649A DE 2501649 C3 DE2501649 C3 DE 2501649C3
Authority
DE
Germany
Prior art keywords
papaverine
thiophene
carboxylic acid
acid salt
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2501649A
Other languages
German (de)
English (en)
Other versions
DE2501649A1 (de
DE2501649B2 (de
Inventor
Edgar Bures-Sur-Yvette Sache (Frankreich)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Publication of DE2501649A1 publication Critical patent/DE2501649A1/de
Publication of DE2501649B2 publication Critical patent/DE2501649B2/de
Application granted granted Critical
Publication of DE2501649C3 publication Critical patent/DE2501649C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE2501649A 1974-01-16 1975-01-16 Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel Expired DE2501649C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7401460A FR2257277B1 (enExample) 1974-01-16 1974-01-16

Publications (3)

Publication Number Publication Date
DE2501649A1 DE2501649A1 (de) 1975-07-17
DE2501649B2 DE2501649B2 (de) 1979-03-15
DE2501649C3 true DE2501649C3 (de) 1979-11-08

Family

ID=9133551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2501649A Expired DE2501649C3 (de) 1974-01-16 1975-01-16 Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (14)

Country Link
US (1) US4055648A (enExample)
JP (1) JPS50101514A (enExample)
AU (1) AU506238B2 (enExample)
BE (1) BE824443A (enExample)
CA (1) CA1040202A (enExample)
CH (1) CH605777A5 (enExample)
DE (1) DE2501649C3 (enExample)
DK (1) DK137641B (enExample)
ES (1) ES433702A1 (enExample)
FR (1) FR2257277B1 (enExample)
GB (1) GB1481249A (enExample)
IE (1) IE40461B1 (enExample)
NL (1) NL7500272A (enExample)
SE (1) SE420200B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559403A (en) * 1983-05-19 1985-12-17 Hoffmann-La Roche Inc. Substituted isoquinolines
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027722A (en) * 1934-04-04 1936-01-14 Univ Minnesota Board Of Therapeutic agent
US2507086A (en) * 1949-02-19 1950-05-09 New York Quinine And Chemical Method for producing pure papaverine hydrochloride
FR2129833B1 (enExample) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay

Also Published As

Publication number Publication date
US4055648A (en) 1977-10-25
IE40461L (en) 1975-07-16
DE2501649A1 (de) 1975-07-17
GB1481249A (en) 1977-07-27
ES433702A1 (es) 1976-12-01
FR2257277A1 (enExample) 1975-08-08
JPS50101514A (enExample) 1975-08-12
DK137641C (enExample) 1978-09-25
NL7500272A (nl) 1975-07-18
SE7500371L (enExample) 1975-07-17
CH605777A5 (enExample) 1978-10-13
CA1040202A (en) 1978-10-10
DK8975A (enExample) 1975-09-15
AU506238B2 (en) 1979-12-20
IE40461B1 (en) 1979-06-06
BE824443A (fr) 1975-07-16
AU7726575A (en) 1976-07-15
DK137641B (da) 1978-04-10
DE2501649B2 (de) 1979-03-15
SE420200B (sv) 1981-09-21
FR2257277B1 (enExample) 1978-02-03

Similar Documents

Publication Publication Date Title
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
CH670952A5 (enExample)
DE2513940A1 (de) Pharmazeutische zubereitung
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2660486C2 (de) Verwendung von 2-Hydroxymethyl-3,4,5-trihydroxypiperidin als Arzneimittel
EP1001756A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE2633891C2 (de) Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
DE2755017C2 (enExample)
DE69426317T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation
DE2916880C2 (de) Arzneimittel mit sedativer und schlafinduzierender Wirkung
DE3231571C2 (enExample)
DE1617508C3 (de) Antidepressive Mittel
DE2621227C3 (de) Nichtdepolarisierendes Myorelaxans
DE60206467T2 (de) Entgiftende phytotherapeutische Zusammensetzung aus zwei Pflanzenextrakten und Verfahren zu deren Herstellung
DE2551962C3 (de) Verwendung eines Extraktes aus verschiedenen Spezies von Helleborus
DE2245826C3 (de) Salze von N-Cyano-äthyl-N'-m-chlorphenyl-piperazin
DE1960273C (de) Arzneimittel mit den Blut Cholesterin spiegel erniedrigender Wirksamkeit
DE69524949T2 (de) Eisen-Chelatierformulierung und Verfahren zu ihrer Herstellung
DE1792295C (de) Pharmazeutisches Präparat enthaltend 1-Aminomethyladamantan. Ausscheidung aus: 1468769
WO2008037416A2 (de) Verwendung von theogallin zur behandlung von mentalen konzentrationsleistungsstörungen, drepression und demenz
DE2805165A1 (de) Gitoxin enthaltendes arzneimittel und verfahren zu seiner herstellung
DD216464A5 (de) Verfahren zur isolierung von physiologisch aktiven pterocarpan-verbindungen
DE1218457B (de) Verfahren zur Herstellung von Dihydrochinidingalakturonat und Dihydrochinidinpolygalakturonat

Legal Events

Date Code Title Description
BI Miscellaneous see part 2
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee